When is informed consent form translation required in Canada? For clinical trial sponsors, contract research organizations (CROs) and research teams, the answer depends on the participants being recruited, the applicable rules and the research ethics board (REB) reviewing the study. A translated informed consent form must communicate the trial clearly enough for participants to make an informed choice—not merely reproduce the English wording.
There is no single nationwide list of mandatory languages for every clinical trial consent form. Canadian informed consent translation requirements are shaped by federal drug-trial rules, good clinical practice, research ethics guidance, provincial law and site-specific REB procedures. This guide explains when French or another language may be needed, what documents to translate, and how to prepare an accurate, review-ready consent package.
When Are Translated Informed Consent Forms Required in Canada?
| Layer | What it requires | Source |
| Federal clinical trials (drugs) | Written informed consent, obtained under applicable law, after the participant has been informed of the risks, benefits and all other aspects needed to decide | Food and Drug Regulations, C.05.010(h) |
| Good clinical practice | Consent information in language the participant can understand, as non-technical as practical | ICH E6, implemented in its R3 version by Health Canada on April 1, 2026 |
| Research funded by federal agencies | Full disclosure of all information needed for an informed decision | TCPS 2 (2022), Chapter 3 |
| Quebec | Written consent is generally required for research that could affect personal integrity, subject to an REB-authorized exception; French-language service obligations also apply in relevant settings | Civil Code of Quebec, art. 24; Charter of the French language |
| Ontario | French services from designated agencies, including some hospitals | French Language Services Act |
| New Brunswick | Services in English and French from public institutions, including the regional health authorities | Official Languages Act of New Brunswick |
| Every study | The languages your REB requires for the population you recruit | REB policy and approval letter |
Federal Informed Consent Requirements for Clinical Trials in Canada
For drug clinical trials, section C.05.010 of the Food and Drug Regulations requires the sponsor to ensure that written informed consent, “given in accordance with the applicable laws governing consent”, is obtained from every participant before they take part, and only after they have been informed of the risks, the anticipated benefits and all other aspects of the trial needed to make a decision.
The federal provision does not prescribe a single language for every informed consent document. Instead, the study team must make the consent information understandable to each prospective participant. A trial recruiting French-speaking participants may need a Canadian French consent form; for other languages, the REB may require translated written materials or approve a documented consent process involving a qualified language intermediary. These arrangements should be confirmed before recruitment starts.
Good clinical practice adds detail. The ICH E6 guideline has long required that the oral and written information about a trial be as non-technical as practical and understandable to the participant. Health Canada implemented ICH E6(R3) on April 1, 2026. For multinational studies, US rules point the same way: 21 CFR 50.20 requires the information given to participants to be “in language understandable to the subject”.
TCPS 2 and Research Ethics Board Approval of Translated Consent Forms
Research funded by Canada’s three federal research agencies must follow the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2, 2022). Chapter 3 sets out the consent process. Article 3.2 requires researchers to give prospective participants full disclosure of all information necessary to make an informed decision. Most institutions apply TCPS 2 to all their research, whatever the funding source.
The TCPS 2 consent guidance emphasizes understanding and the appropriate use of language intermediaries. For multilingual recruitment, researchers should explain how participants will understand the study information, ask questions and provide free, informed consent. REBs may ask to review each translated informed consent form, verify version control or see a plan for qualified language assistance. The exact submission and approval process varies by board; obtain the relevant requirements before using a translation with participants.
Informed Consent Form Translation Rules by Canadian Province
Quebec
Under article 24 of the Civil Code of Quebec, consent to research that could interfere with a person’s integrity must generally be in writing; a research ethics committee may authorize another form of consent where the circumstances justify it. Article 21 adds protections for research involving minors and adults unable to consent for themselves. The Charter of the French language also sets French-language rights and obligations for relevant health and social services.
For clinical trials recruiting French-speaking participants in Quebec, a Canadian French informed consent form should be planned from the outset. English or additional language versions may also be necessary for the study population and site. Translation teams should use accurate Quebec legal and clinical terminology for concepts such as an authorized representative, compensation and withdrawal of consent, and follow the reviewing REB’s document requirements.
Ontario
Ontario does not impose the same French-language requirements on every hospital. The French Language Services Act establishes obligations for designated service providers, including certain fully or partially designated hospitals. This does not automatically determine every clinical trial consent language: study teams must also consider the REB, site and recruitment population. French informed consent translations may be needed for Francophone participants in Ottawa and northeastern Ontario, while multilingual Toronto studies may also require Punjabi, Mandarin, Cantonese or Tagalog materials.
New Brunswick
New Brunswick is Canada’s only officially bilingual province. Its Official Languages Act provides rights to communicate with provincial institutions, including regional health authorities, in English or French. Clinical trial teams recruiting through Horizon or Vitalité should assess English and French consent needs early, in coordination with their sites and REB rather than assuming that every protocol requires both versions in all circumstances.
Other provinces and territories
Across other provinces and territories, language requirements may arise from applicable laws, institutional policies, the recruitment plan and the reviewing REB. Teams recruiting participants who are not comfortable reading the source language should plan a suitable translated consent form or an REB-approved language-assistance process. French-language health-service obligations and territorial language legislation may also affect particular sites, so confirm local requirements early.
Which Clinical Trial Documents Need Translation Alongside the Consent Form?
REBs approve a set of participant-facing documents, not just the consent form. When you plan translations, include:
- The main informed consent form and any optional consent sections (genetic testing, biobanking, future use of data)
- Assent forms for minors, written for the child’s age
- Recruitment material: posters, letters, emails, scripts and social media posts
- Patient diaries, questionnaires and instructions for using study devices or apps
- Information letters for amendments and re-consent, which often arrive on short deadlines
- Contact details, compensation information and the REB contact block, which must stay consistent across every version
Informed Consent Translation Checklist for Sponsors and CROs
- Confirm consent languages and REB requirements before translation starts, including any need for a translation certificate, independent revision or back translation.
- Use the current source version. Ideally, translate the finalized, approved consent form; if translation must start earlier, track every change and reconcile all target-language versions before submission.
- Keep the version number and date in every language, and match them to the English source so the REB can check them side by side.
- Use Canadian terminology. A consent form for Quebec should use Canadian French terms for health system concepts, not European ones. Our English to Canadian French medical glossary lists common examples.
- Keep the reading level low. If the English is hard to read, the translation will be too. Our plain language checklist helps simplify the source first.
- Use one glossary for the whole study, so that the drug name, the procedures and the risks are named the same way in the consent form, the diaries and the questionnaires.
- Plan the layout. French text is often longer than English, so signature blocks and initials boxes need room. Arabic, Hebrew and Persian also read right to left.
- Budget for amendments and re-consent. When an amendment changes participant-facing information, determine which translated forms need updating and what the REB requires before the revised materials are used.
Common REB Submission Problems With Translated Informed Consent Forms
Before submitting translated informed consent forms to a research ethics board, watch for common version-control, terminology and completeness problems. These issues can delay document review even when the translation reads naturally:
- Version mismatch. The French form is based on version 3 of the English form, but the REB is approving version 4. A single changed paragraph is enough to trigger a request for a new translation.
- Missing sections. An optional consent for biobanking or future contact was added to the English form late, and nobody sent it for translation.
- Different numbers. The compensation amount, the number of visits or the volume of blood drawn differs between versions, usually because the English was corrected after translation.
- Untranslated contact block. The REB, the study team and the patient ombudsman are listed in English only, or with phone numbers that do not match.
- Legal language translated word for word. Clauses on liability, confidentiality or the right to withdraw read like a contract rather than an explanation for a participant.
- Inconsistent terms. The study drug, the placebo or a procedure has two different names in the same form, which confuses participants and reviewers alike.
An independent, side-by-side review of the approved source and each translated consent form helps catch these issues before REB submission. It should cover clinical meaning, risks, dates, figures, version identifiers and contact details.
Professional Informed Consent Form Translation for Canadian Clinical Trials
Clinical trial consent forms must be accurate, clear to participants and consistent with the study version approved for use. At Mediwords, these documents are translated by specialized medical linguists working into their native language, independently revised by a second linguist and checked for terminology, risks, numbers, dates and contact details. Our informed consent form translation service supports consent documents and participant materials, while our clinical trial translation team works with sponsors and CROs on multilingual study packages and time-sensitive amendments.
FAQ: Informed Consent Translation Requirements in Canada
When is a French informed consent form required in Canada?
Not for every study across Canada. French informed consent forms are commonly needed when recruiting Francophone participants in Quebec and may be required by site, service or REB policies elsewhere, including New Brunswick and designated Ontario settings. Quebec’s written-consent rule has a limited REB-authorized exception and does not itself specify a language. Confirm your study’s languages with the responsible REB.
Does the REB need to approve translated consent forms?
Many REBs require translated participant-facing documents to be submitted for review or approval before use. Requirements for translation certificates, independent review, back translation and amendment submissions differ by board. Follow the study’s REB instructions.
Can an interpreter replace a translated consent form?
Sometimes. An REB may permit a documented consent process using a qualified language intermediary, with suitable written documentation or a short-form procedure. Whether this is acceptable depends on the study, the participant and the board’s policies; regularly used recruitment languages often warrant translated full consent forms.
Should the consent form be back translated?
Not automatically. Some REBs or sponsors request back translation, while others accept qualified translation and independent revision. Patient-reported outcome instruments may follow a separate linguistic validation methodology, including back translation when appropriate.
How long does it take to translate a consent form?
Timing depends on the length, complexity, source-file quality, number of languages and review requirements. A professional quote should confirm the turnaround for translation and independent revision; allow additional time for REB review and any required amendments.
Sources
- Government of Canada, Food and Drug Regulations, section C.05.010
- Health Canada, Implementation of the ICH E6(R3) guideline: Notice to stakeholders
- Panel on Research Ethics, Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, TCPS 2 (2022)
- Government of Quebec, Civil Code of Quebec, articles 21 and 24
- Government of Quebec, Charter of the French language
- Government of Ontario, French Language Services Act, R.S.O. 1990, c. F.32
- Government of New Brunswick, Official Languages Act, S.N.B. 2002, c. O-0.5
- Steps to Justice, What are my rights to receive health care services in French?
- US Code of Federal Regulations, 21 CFR 50.20, General requirements for informed consent
